H+ Advocacy

2021 H+ Advocacy Text

Humanity+ sees its role as the primary advocate for positive transhumanist values. Humanity+ feels that these values and the goals of the transhumanist agenda are consequential for humanity’s well-being. Humanity+ wants to inform its members and the public about the ethical uses of technology and evidence-based science to advance human existence. The nature and scope of human existence includes the growth, aspirations, circumstances and conflicts that humanity faces today and in the future.


Global Leaders and Organizations that are preparing us for the Future are known for exploring opportunities not only within their fields, but on a broader scope. Their intellectual impact helps the forward movement of education and lifelong learning. The broader impact is the ability to connect unique ideas to projects, from the most immediate needs of society to future impacts of technology that implement a keen foresight to steer us toward a positive future. The Humanity+ Advocacy aims to impact change. We have the knowledge to equip you with the tools, resources and mindset to navigate your own transformative journey.


This is Humanity+’s network of members, advisors, associates and partners. Areas include entrepreneurs and innovators in the fields of science, technology, philosophy, humanities and the arts.

Dr. Martine Aliana Rothblatt is an American lawyer, author, and entrepreneur. She is an Advisor to Humanity+. Rothblatt graduated from University of California, Los Angeles with a combined law and MBA degree in 1981, then began to work in Washington, D.C., first in the field of communications satellite law, and eventually in life sciences projects like the Human Genome Project. She is the founder and Chairwoman of the Board of United Therapeutics. She was also the CEO of GeoStar and the creator of SiriusXM Satellite Radio. She is known for being the top earning CEO in biopharmaceutical industry in 2018.

Dr. Max More is a philosopher and futurist who writes, speaks, and consults on advanced decision-making about emerging technologies. Advisor to Humanity+.  More graduated from Oxford University and is the founder of Extropy Institute. He is currently president and CEO of the Alcor Life Extension Foundation, an organization he joined in 1986. He is the author of Proactionary Principle, the concept of Morphological Freedom, and one of the most interviewed strategic philosophers about humanity and the future. He is known for being the author of modern transhumanism

Dr. Aubrey David Nicholas Jasper de Grey is an English author and biomedical gerontologist. He is the Chief Science Officer of the SENS Research Foundation and VP of New Technology Discovery at AgeX Therapeutics, Inc. He is editor-in-chief of the academic journal Rejuvenation Research, author of The Mitochondrial Free Radical Theory of Aging (1999) and co-author of Ending Aging (2007). He is known for his view that medical technology may enable human beings alive today not to die from age-related causes. He is also an amateur mathematician who has contributed to the study of the Hadwiger–Nelson problem.

Dr. Natasha Vita-More is a strategic designer, author, speaker and innovator within the scientific and technological framework of human enhancement and life extension. She is Executive Director of Humanity+.  Her interests are located within the ethical uses of science and technology and socio-political implications of revolutionary advances impacting humanity’s future. Vita-More was awarded a PhD from University of Plymouth, UK.  She was the scientific Lead on a scientific breakthrough proving for the first time that cryonic technology does not destroy the long-term memory of the simplest multi-cellular organisms. She is the designer of the first whole body prosthetic, the prototype known as Primo Posthuman.

Dr. Anders Sandberg s a researcher, science debater, futurist, transhumanist and author. He holds a Ph.D. in computational neuroscience from Stockholm University, and is currently a James Martin Research Fellow at the Future of Humanity Institute at Oxford University. Sandberg’s research centers on societal and ethical issues surrounding human enhancement and new technology, as well as on assessing the capabilities and underlying science of future technologies. His research includes work on cognitive enhancement (methods, impacts, and policy analysis); a technical roadmap on whole brain emulation; on neuroethics; and on global catastrophic risks, particularly on the question of how to take into account the subjective uncertainty in risk estimates of low-likelihood, high-consequence risk.

Ms. Sonia Arrison is an author who writes about the impacts of technology on human life, including her bestselling book 100 Plus: How the Coming Age of Longevity Will Change Everything, From Careers and Relationships to Family and Faith. Arrison was an Associate Founder of Singularity University. Arrison studied political science at the University of Calgary and became interested in the political impact of the Internet, which eventually led to her becoming director of technology studies at the Pacific Research Institute, a libertarian think tank headquartered in San Francisco, in the early 2000s.

Dr. Ben Goertzel is the founder and CEO of SingularityNET, a blockchain-based AI marketplace. Goertzel is also the chief scientist of financial prediction firm Aidyia Holdings and robotics firm Hanson Robotics; chairman of AI software company Novamente LLC, a privately held software company; chairman of the Artificial General Intelligence Society and the OpenCog Foundation; chair of futurist nonprofit Humanity+; scientific advisor of biopharma firm Genescient Corp.; advisor to Singularity University; research professor in the Fujian Key Lab for Brain-Like Intelligent Systems at Xiamen University of Technology, China; chair of the Artificial General Intelligence (AGI) conference series, and an American author and researcher in the field of artificial intelligence. He was the Director of Research of the Machine Intelligence Research Institute (formerly the Singularity Institute).